WaferGen Q3 Revenues Nearly Double | GenomeWeb

NEW YORK (GenomeWeb News) – WaferGen Bio-system's third-quarter revenues almost doubled year over year, the company said in its quarterly earnings document filed with the US Securities and Exchange Commission on Friday.

The Fremont, Calif.-based firm said that revenues reached $176,608 during the quarter, compared to $89,088 a year ago. In its Form 10-Q, WaferGen said that the increase was driven primarily from the sale of an open platform real-time PCR system, but that growth was offset by a reduction in sales of its real-time PCR Chip panels.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Through a transcriptome study, researchers home in on the activity of inflammation-linked genes in chronically lonely people.

Determining who is and is not an author and where a researcher should fall on a list of authors can be a tricky task, Nature News writes.

In PNAS this week: variant protective against Alzheimer's disease, effect of whole-genome duplication on methylation in rice, and more.

Genome editing is also bringing up questions when applied to farm animals, the New York Times reports.